Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Capital World Investors VNTR Venator Materials PLC 13D 18% 3y
Eureka Therapeutics, Inc. ESLA Estrella Immunopharma, Inc. 13D 71.8% 3y
Dan Wilks DWSN Dawson Geophysical Co 13D/A 80.03% 3y
Mark E. Strome ZIVO Zivo Bioscience, Inc. 13D/A 5.3% 3y
Rithm Capital Corp. SCU Sculptor Capital Management, Inc. Class A Common Stock 13D/A 12.8% 3y
Harraden Circle Investments, LLC ACBA Ace Global Business Acquisition Limited Ordinary Shares 13G 5.25% 3y
Murchinson Ltd. NNDM Nano Dimension Ltd. 13D/A 6.6% 3y
Steamboat Capital Partners, LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 9.2% 3y
Sherborne Investors Management LP NAVI Navient Holdings, Inc. 13D/A 25% 3y
FJ Capital Management LLC BANC Banc Of California, Inc. 13G 5.02% 3y
Brookfield Oaktree Holdings, LLC GTX Garrett Motion Inc. 13D/A 13.9% 3y
Trevor Bezdek GDRX GoodRx Holdings, Inc. 13D/A 5.5% 3y
Douglas Joseph Hirsch GDRX GoodRx Holdings, Inc. 13D/A 5.5% 3y
Deep Track Capital, LP TRML Tourmaline Bio, Inc. Common Stock 13G 8.93% 3y
John Michael DiMaio MDAI Spectral AI, Inc. 13D 17.1% 3y
Steamboat Capital Partners, LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 1.3% 3y
Pfizer Inc TRML Tourmaline Bio, Inc. Common Stock 13G 6.26% 3y
Commodore Capital LP NKTX Nkarta, Inc. 13G 5.6% 3y
GLAZER CAPITAL, LLC HCCI Heritage-Crystal Clean, Inc. 13G/A 0% 3y
272 Capital LP SQNS Sequans Communications 13D/A 18.5% 3y
Quogue Capital LLC IOVA Iovance Biotherapeutics, Inc. 13D/A 15.84% 3y
Cleveland Avenue Food and Beverage Fund II, LP PRST Presto Technologies, Inc. Common Stock 13D 17.3% 3y
CWAM LC Sponsor LLC LCW Learn CW Investment Corporation Class A Ordinary Shares 13D/A 42.8% 3y
SIT INVESTMENT ASSOCIATES INC CLM Cornerstone Strategic Investment Fund, Inc. 13G/A 4.68% 3y
Galloway Capital Partners, LLC WYY Widepoint Corp 13D 4.31% 3y
Lux Donn S. CASK Sempreon, Inc 13D/A 36.2% 3y
Silver Lake West HoldCo, L.P. EDR Endeavor Group Holdings, Inc. 13D/A 45.1% 3y
Pershing Square Capital Management, L.P. HHH Howard Hughes Holdings Inc. 13D/A 34.9% 3y
Frazier Life Sciences VIII, L.P. ARQT Arcutis Biotherapeutics, Inc. 13D/A 9.4% 3y
Ben M. Brigham AESI Atlas Energy Solutions Inc. 13D/A 45.1% 3y
Castle Creek Capital Partners VIII, LP BWB Bridgewater Bancshares Inc 13D/A 7.9% 3y
Erich Spangenberg MDAI Spectral AI, Inc. 13D/A 32.68% 3y
Braden Ferrari BTLN Brightline Interactive, Inc. 13G/A 5.67% 3y
MILLENNIUM MANAGEMENT LLC MRVI Maravai Lifesciences Holdings, Inc. 13G 5.3% 3y
Deerfield Management Company, L.P. NKTX Nkarta, Inc. 13G 6.93% 3y
Anson Funds Management LP VIEW View, Inc. Class A Common Stock 13D 2.2% 3y
FR Capital Holdings, L.P. NTBL Notable Labs, Ltd. Ordinary Shares 13G 11.6% 3y
B Capital Fund II, L.P. NTBL Notable Labs, Ltd. Ordinary Shares 13G 11.2% 3y
Hong Seng Technology Limited BLRX BioLineRx Ltd. 13D 9.5% 3y
Cicw Holdings Limited CCG Cheche Group Inc. 13G 10% 3y
1901 Lux Holdings, LP HHRS Hammerhead Energy Inc. Class A Common Stock 13D/A 0% 3y
GAMCO INVESTORS, INC. ET AL SCPL SciPlay Corporation Class A Common Stock 13D/A 0% 3y
Saba Capital Management, L.P. EMO ClearBridge Energy Midstream Opportunity Fund Inc. 13D/A 20.99% 3y
Saba Capital Management, L.P. MPA Blackrock Muniyield Pennsylvania Quality Fund 13D/A 13.47% 3y
STONEPEAK MAGNET HOLDINGS LP AKU Akumin Inc. Common Stock (DE) 13D/A 19.1% 3y
transcosmos inc. PFSW PFSweb, Inc. 13D/A 0% 3y
OR Nazar M. Khan WULF Terawulf Inc. 13D 9.1% 3y
Sea Otter Advisors LLC OCAX OCA Acquisition Corp. Class A Common Stock 13G/A 3.64% 3y
Bruce A. Cassidy, Sr. LPTV Loop Media, Inc. 13D/A 19.9% 3y
René Holeček VSTO Vista Outdoor Inc. 13D 5.7% 3y